At Hims & Hers, our mission has always been clear: make healthcare accessible, more affordable, and more personal. What began as a simpler way to access care has grown into a technology-driven platform reshaping how care is delivered, built to support millions of people across a wide and expanding range of health needs.
Today, alongside our Q1 results, we shared something even more important: our vision for the future. A roadmap for what this company can become, and how we plan to get there.
We’ve set a bold target: $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA by 2030. That number reflects our ambition – but also our conviction. It’s grounded in what we’ve already built, the trust we’ve earned, and the scale we’re starting to unlock.
These aren’t just numbers. They’re grounded in a proven model, a strong foundation, and a fast-growing, loyal customer base. More than that, they reflect the increasing role we can play in helping people take control of their daily health in the U.S. and around the world.
This is our roadmap. To get there, we’re focused on five priorities, each unlocking new ways to serve our customers more deeply and more broadly.
The future of care should be built for you, and it should feel like that. We’re already offering hundreds of personalized treatments, and we’re just scratching the surface. Over the next few years, we expect to expand that to thousands, powered by lab testing, wearable data, and AI. The goal: faster feedback, better outcomes, and care that adapts to each person’s unique needs.
We’ve seen incredible momentum in areas like weight loss, which we believe is proof that when care is simple and personalized, people engage. This year, we plan to expand into conditions like low testosterone and menopause, which affect millions. With lab testing and new treatment capabilities for providers, we’re also exploring new areas like longevity, sleep, and preventive care, all focused on helping people feel their best over the long term.
As we grow, we stay personal. Tools like MedMatch by Hims & Hers and clever routing are improving how providers engage with their patients, and we’re building AI-powered support across therapy, nutrition, and coaching, so every experience feels seamless, proactive, and human. The future of care puts people first. It connects diagnosis, treatment, and delivery in a way that feels seamless, supportive, and tailored to each individual. That’s the future we’re building.
Our collaboration with Novo Nordisk shows what’s possible when trusted medicine meets personalized care. But we’re going further. We’re building an ecosystem, connecting pharma partners, clinical providers, and our platform, to deliver the best healthcare experience possible. We’re confident in our ability to be the ecosystem player that helps everyone win, while delivering access to the best care for the people we serve.
Healthcare challenges are global, and so is demand for simpler, more transparent, more personalized healthcare. Our early success in the UK gives us confidence we can scale globally, to offer access to personalized, transparent, high-quality care to people everywhere. More on that soon.
We’re entering a new era of growth, defined by deeper personalization, broader impact, and a relentless focus on the customer. From expanding diagnostics to launching entirely new specialties, we’re evolving fast, with more speed, more precision, and more ambition than ever before.
The foundation is built. The roadmap is clear. And we’re just getting started.
